{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:18:41Z","timestamp":1771013921782,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.pupt.2007.05.002","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T08:54:55Z","timestamp":1180083295000},"page":"264-275","source":"Crossref","is-referenced-by-count":33,"title":["Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma"],"prefix":"10.1016","volume":"21","author":[{"given":"E.D.","family":"Bateman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Linnhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Homik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Freudensprung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Smau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Engelst\u00e4tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2007.05.002_bib1","unstructured":"NIH. National Institutes of Health National Heart Lung and Blood Institute. National asthma education and prevention program. Expert panel report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics. J Allergy Clin Immunol 2002; 110: S141\u2013S219."},{"key":"10.1016\/j.pupt.2007.05.002_bib2","unstructured":"GINA. Global Initiative for Asthma. National Institutes of Health, National Heart, Lung and 338 Blood Institute. \u3008www.ginasthma.com\u3009. 2005."},{"issue":"3 Suppl","key":"10.1016\/j.pupt.2007.05.002_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0091-6749(03)01859-1","article-title":"Inhaled corticosteroids: past lessons and future issues","volume":"112","author":"Allen","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.pupt.2007.05.002_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(99)00019-4","article-title":"Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects","volume":"83","author":"Cave","year":"1999","journal-title":"Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.pupt.2007.05.002_bib5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pupt.2007.05.002_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.126.1.213","article-title":"The local side effects of inhaled corticosteroids: current understanding and review of the literature","volume":"126","author":"Roland","year":"2004","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.pupt.2007.05.002_bib7","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1034\/j.1398-9995.2001.00100.x","article-title":"Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device","volume":"56","author":"Dubus","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.pupt.2007.05.002_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved?","volume":"170","author":"Bateman","year":"2004","journal-title":"Am J Resp Crit Care Med"},{"issue":"2","key":"10.1016\/j.pupt.2007.05.002_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1440-1843.2005.00688.x","article-title":"Fluticasone given once versus twice a day: meta-analysis","volume":"10","author":"Masoli","year":"2005","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.pupt.2007.05.002_bib10","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1378\/chest.124.4.1584","article-title":"Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day","volume":"124","author":"Purucker","year":"2003","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.pupt.2007.05.002_bib11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1183\/09031936.01.00099701","article-title":"Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening","volume":"17","author":"Postma","year":"2001","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.pupt.2007.05.002_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1398-9995.2004.00750.x","article-title":"Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma","volume":"60","author":"Chapman","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.pupt.2007.05.002_bib13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.rmed.2005.05.024","article-title":"Once-daily ciclesonide 80 or 320\u03bcg for 12 weeks is safe and effective in patients with persistent asthma","volume":"99","author":"Langdon","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2007.05.002_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000062132","article-title":"Ciclesonide: an on-site activated steroid","volume":"31","author":"Dietzel","year":"2001","journal-title":"Prog Respir Res"},{"issue":"1","key":"10.1016\/j.pupt.2007.05.002_bib15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/jpet.103.059592","article-title":"In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide","volume":"309","author":"Stoeck","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pupt.2007.05.002_bib16","first-page":"201","article-title":"Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide","volume":"12","author":"Rohatagi","year":"2005","journal-title":"Am J Ther"},{"issue":"7","key":"10.1016\/j.pupt.2007.05.002_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/00003088-200443070-00004","article-title":"Pharmacokinetics of [14C] ciclesonide after oral and intravenous administration to healthy subjects","volume":"43","author":"Nave","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.pupt.2007.05.002_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pupt.2005.02.012","article-title":"Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide","volume":"18","author":"Nave","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.pupt.2007.05.002_bib19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.pupt.2005.10.003","article-title":"Comparable efficacy of ciclesonide once daily versus fluticasone propionate twice daily in asthma","volume":"19","author":"Buhl","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"issue":"Suppl.","key":"10.1016\/j.pupt.2007.05.002_bib20","first-page":"A73","article-title":"Efficacy and tolerability of ciclesonide (MDI) and fluticasone propionate (Diskus\u00ae) in patients with moderate asthma","volume":"3","author":"Boulet","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.pupt.2007.05.002_bib21","first-page":"255s","article-title":"Ciclesonide 80\u03bcg or 160\u03bcg once daily is comparable to fluticasone propionate 88\u03bcg twice daily in the treatment of asthma patients","volume":"1736","author":"Magnussen","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2007.05.002_bib22","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health-related quality in asthma: development of a questionnaire for use in clinical trials","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2007.05.002_bib23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1378\/chest.115.5.1265","article-title":"Validation of a standardized version of the Asthma Quality of Life Questionnaire","volume":"115","author":"Juniper","year":"1999","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.pupt.2007.05.002_bib24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jaci.2005.08.037","article-title":"Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma","volume":"116","author":"Pearlman","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.pupt.2007.05.002_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2125.2004.02108.x","article-title":"Effects of hydrofluoroalkane formulations of ciclesonide 400 microgram once daily vs fluticasone 250 micro g twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma","volume":"58","author":"Lee","year":"2004","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.pupt.2007.05.002_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pupt.2005.01.004","article-title":"Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5\u2019monophosphate in asthmatic patients","volume":"18","author":"Derom","year":"2005","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.pupt.2007.05.002_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1378\/chest.127.3.851","article-title":"Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.pupt.2007.05.002_bib28","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.rmed.2005.12.004","article-title":"Effect of ciclesonide and fluticasone on exhaled nitric oxide in patients with mild allergic asthma","volume":"100","author":"Zietkowski","year":"2006","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.pupt.2007.05.002_bib29","first-page":"CD002310","article-title":"Inhaled fluticasone versus inhaled beclomethasone or inhaled budesonide for chronic asthma in adults and children","author":"Adams","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.pupt.2007.05.002_bib30","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.clinthera.2005.11.005","article-title":"Comparison of the efficacy of ciclesonide 160\u03bcg QD and budesonide 200\u03bcg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study","volume":"27","author":"Niphadkar","year":"2005","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.pupt.2007.05.002_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.rmed.2005.11.030","article-title":"Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma","volume":"100","author":"Boulet","year":"2006","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.pupt.2007.05.002_bib32","first-page":"85","article-title":"Defining the effects of an inhaled corticosteroid and long-acting beta-agonist on therapeutic targets","volume":"24","author":"Settipane","year":"2003","journal-title":"Allergy Asthma Proc"},{"issue":"2","key":"10.1016\/j.pupt.2007.05.002_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1177\/0091270004271094","article-title":"Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma","volume":"45","author":"Richter","year":"2005","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.pupt.2007.05.002_bib34","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jaci.2005.01.066","article-title":"Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide","volume":"115","author":"Agertoft","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.pupt.2007.05.002_bib35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1081-1206(10)61117-9","article-title":"Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma","volume":"94","author":"Lipworth","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pupt.2007.05.002_bib36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1378\/chest.128.3.1104","article-title":"Ciclesonide, a novel inhaled steroid, does not affect HPA-axis function in patients with moderate-to-severe persistent asthma","volume":"128","author":"Szefler","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.pupt.2007.05.002_bib37","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jaci.2005.12.047","article-title":"Ciclesonide, administered once daily, has no effect on growth velocity in prepubertal children with mild, persistent asthma","volume":"117","author":"Skoner","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pupt.2007.05.002_bib38","unstructured":"Global asthma physician and patient (GAPP) survey 2006. \u3008www.gappsurvey.org\u3009. Last accessed June 2006."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553907000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553907000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T22:57:40Z","timestamp":1546815460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553907000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1094553907000454"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2007.05.002","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}